COVID-19 Clinical Trials

A listing of COVID-19 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 319 clinical trials
Featured trial
Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)  

Primary Objective: To evaluate the efficacy of treatment with dupilumab to reduce sinus opacification in a population with allergic fungal rhinosinusitis (AFRS) Secondary Objectives: To evaluate the efficacy of treatment with dupilumab to reduce sinus opacification in a population with allergic fungal rhinosinusitis (AFRS) at Week 24 To assess the …

  • 123 views
  • 19 May, 2023
  • 5 locations
Featured trial
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM  

This is a randomized, multicenter, Phase 3, open-label study evaluating subcutaneous (SC) vs intravenous (IV) administration of isatuximab in combination with pomalidomide and dexamethasone (Pd) in RRMM patients (study participants) who have received at least 1 prior line of therapy including lenalidomide and a proteasome inhibitor (PI). Eligible participants will …

  • 15 views
  • 17 May, 2023
  • 5 locations
Featured trial
SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients (CARMEN-LC03)  

Primary Objectives: Study is designed with two primary endpoints that will be analyzed on randomized participants at the time of the cut-off date for each given analysis (progression free survival [PFS] and overall survival [OS]) Study success is defined either on PFS or OS The primary objective is to determine …

  • 181 views
  • 12 May, 2023
  • 5 locations
Featured trial
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma (TIDE-asthma)  

This is a parallel, Phase 2, global, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, four-arms study for treatment. The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with amlitelimab in adult participants with moderate-to-severe asthma. Study details include: The study duration (per participant) will be …

  • 33 views
  • 19 May, 2023
  • 6 locations
Covid-19 Virtual Recovery Study

The purpose of this study is to determine the effects of respiratory muscle training (RMT) and nasal breathing on patients who have been infected with the SARS-CoV2 virus and continue to have lingering symptoms.

Accepts healthy volunteers
  • 5 views
  • 09 Apr, 2023
  • 1 location
Jump Start Plus COVID-19 Support

The purpose of the study is to further develop and examine the Jump Start Plus COVID Support (JS+CS) program, which encourages improved psychosocial functioning by promoting resiliency in childcare centers.

Accepts healthy volunteers
  • 0 views
  • 07 Oct, 2022
  • 1 location
AGILE (Early Phase Platform Trial for COVID-19)

The AGILE platform master protocol allows incorporation of a range of identified and yet-to-be-identified candidates as potential treatments for adults with COVID-19 into the trial. Candidates

  • 122 views
  • 07 Oct, 2022
  • 3 locations
Detection of COVID-19 Using Breath Analysis - Validation Study (COVID-19)

DETECTION OF THE 2019 NOVEL CORONAVIRUS (SARS-CoV-2) USING BREATH ANALYSIS- VALIDATION STUDY

Accepts healthy volunteers
  • 0 views
  • 04 Oct, 2022
  • 1 location
ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19) (ARVAC-F2/3-002)

The goals of this clinical trial are: Stage 1: to test a recombinant vaccine based on the Gamma variant against SARS-CoV-2 in healthy adult volunteers, previously vaccinated against the SARS-CoV-2 virus. Stage 2 (not yet recruitment): to test a recombinant vaccine against SARS-CoV-2 comparing three different versions (Gamma Variant RBD-based …

Accepts healthy volunteers
  • 0 views
  • 08 Apr, 2023
Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.

To evaluate the effectiveness of the single dose Ad26.COV2.S COVID-19 vaccine plus a homologous boostwith Ad26.COV2.S COVID-19 vaccine among Sisonke participants as compared to unboosted

Accepts healthy volunteers
  • 43 views
  • 04 Oct, 2022
  • 31 locations